1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Digital Mental Health Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Digital Mental Health Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Mergers & Acquisitions
5.3. Typical Journey of a Mental Health Patient
5.4. Covid-19 Impact Analysis
6. Global Digital Mental Health Market Analysis and Forecast, by Functionality
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Functionality, 2017–2031
6.3.1. Clinical Functionality
6.3.1.1. Electronic Health Records (EHR)
6.3.1.2. Clinical Decision Support (CDS)
6.3.1.3. Care Plans/Health Management
6.3.1.4. E-Prescribing
6.3.1.5. Telehealth
6.3.1.6. Others
6.3.2. Administrative Functionality
6.3.3. Financial Functionality
6.4. Market Attractiveness Analysis, by Functionality
7. Global Digital Mental Health Market Analysis and Forecast, by Component
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Component, 2017–2031
7.3.1. Software
7.3.2. Devices
7.4. Market Attractiveness Analysis, by Component
8. Global Digital Mental Health Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Digital Mental Health Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Digital Mental Health Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Functionality, 2017–2031
10.2.1. Clinical Functionality
10.2.1.1. Electronic Health Records (EHR)
10.2.1.2. Clinical Decision Support (CDS)
10.2.1.3. Care Plans/Health Management
10.2.1.4. E-Prescribing
10.2.1.5. Telehealth
10.2.1.6. Others
10.2.2. Administrative Functionality
10.2.3. Financial Functionality
10.3. Market Value Forecast, by Component, 2017–2031
10.3.1. Software
10.3.2. Devices
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Functionality
10.6.2. By Component
10.6.3. By End-user
10.6.4. By Country
11. Europe Digital Mental Health Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Functionality, 2017–2031
11.2.1. Clinical Functionality
11.2.1.1. Electronic Health Records (EHR)
11.2.1.2. Clinical Decision Support (CDS)
11.2.1.3. Care Plans/Health Management
11.2.1.4. E-Prescribing
11.2.1.5. Telehealth
11.2.1.6. Others
11.2.2. Administrative Functionality
11.2.3. Financial Functionality
11.3. Market Value Forecast, by Component, 2017–2031
11.3.1. Software
11.3.2. Devices
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Functionality
11.6.2. By Component
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Digital Mental Health Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Functionality, 2017–2031
12.2.1. Clinical Functionality
12.2.1.1. Electronic Health Records (EHR)
12.2.1.2. Clinical Decision Support (CDS)
12.2.1.3. Care Plans/Health Management
12.2.1.4. E-Prescribing
12.2.1.5. Telehealth
12.2.1.6. Others
12.2.2. Administrative Functionality
12.2.3. Financial Functionality
12.3. Market Value Forecast, by Component, 2017–2031
12.3.1. Software
12.3.2. Devices
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia and New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Functionality
12.6.2. By Component
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Digital Mental Health Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Functionality, 2017–2031
13.2.1. Clinical Functionality
13.2.1.1. Electronic Health Records (EHR)
13.2.1.2. Clinical Decision Support (CDS)
13.2.1.3. Care Plans/Health Management
13.2.1.4. E-Prescribing
13.2.1.5. Telehealth
13.2.1.6. Others
13.2.2. Administrative Functionality
13.2.3. Financial Functionality
13.3. Market Value Forecast, by Component, 2017–2031
13.3.1. Software
13.3.2. Devices
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Functionality
13.6.2. By Component
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Digital Mental Health Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Functionality, 2017–2031
14.2.1. Clinical Functionality
14.2.1.1. Electronic Health Records (EHR)
14.2.1.2. Clinical Decision Support (CDS)
14.2.1.3. Care Plans/Health Management
14.2.1.4. E-Prescribing
14.2.1.5. Telehealth
14.2.1.6. Others
14.2.2. Administrative Functionality
14.2.3. Financial Functionality
14.3. Market Value Forecast, by Component, 2017–2031
14.3.1. Software
14.3.2. Devices
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Functionality
14.6.2. By Component
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Cerner Corporation (Oracle)
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Core Solutions, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Holmusk
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. IBM
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Netsmart Technologies, Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. NXGN Management, LLC
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Qualifacts Systems, Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Spring Care, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. The Echo Group
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Medibio
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Linus Healthcare
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/